Alpa Laboratories Ltd
ALPAAlpa Laboratories Ltd
ALPA
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 12.56 | 1.57 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Alpa Laboratories Limited is a pharmaceutical company. The Company operates in the drugs and chemicals segment.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 58.77 | 68.59 | 67.71 | 83.29 | 88.88 | 101.95 | 123.05 | 102.33 | 123.63 | 120.40 | ||||||||||
Raw Materials | 31.86 | 35.79 | 35.93 | 47.31 | 51.42 | 60.62 | 69.24 | 53.67 | 68.68 | 94.93 | ||||||||||
| Power & Fuel Cost | 1.49 | 1.58 | 1.76 | 2.01 | 2.21 | 2.43 | 2.64 | 3.04 | 3.02 | |||||||||||
| Employee Cost | 7.20 | 8.67 | 10.26 | 12.04 | 11.82 | 11.75 | 11.93 | 12.17 | 13.29 | |||||||||||
| Selling & Administrative Expenses | 6.56 | 6.09 | 6.32 | 8.21 | 8.80 | 7.56 | 8.29 | 7.07 | 8.65 | |||||||||||
| Operating & Other expenses | -0.35 | 6.32 | 4.65 | 7.28 | 8.37 | 7.50 | 9.50 | 8.93 | 7.00 | |||||||||||
EBITDA | 12.01 | 10.14 | 8.79 | 6.44 | 6.26 | 12.09 | 21.45 | 17.45 | 22.99 | 25.47 | ||||||||||
| Depreciation/Amortization | 0.83 | 2.78 | 3.07 | 3.12 | 3.16 | 1.23 | 1.66 | 1.33 | 1.95 | 2.21 | ||||||||||
| PBIT | 11.18 | 7.36 | 5.72 | 3.32 | 3.10 | 10.86 | 19.79 | 16.12 | 21.04 | 23.26 | ||||||||||
| Interest & Other Items | 1.45 | 1.71 | 1.07 | 0.57 | 0.20 | 0.08 | 0.22 | 0.22 | 0.36 | 0.38 | ||||||||||
| PBT | 9.73 | 5.65 | 4.65 | 2.75 | 2.90 | 10.78 | 19.57 | 15.90 | 20.68 | 22.88 | ||||||||||
| Taxes & Other Items | 2.89 | 3.12 | 1.83 | 1.74 | 1.06 | 3.54 | 5.47 | 3.31 | 3.90 | 3.91 | ||||||||||
| Net Income | 6.84 | 2.53 | 2.82 | 1.01 | 1.84 | 7.24 | 14.10 | 12.59 | 16.78 | 18.97 | ||||||||||
| EPS | 3.25 | 1.20 | 1.34 | 0.48 | 0.87 | 3.44 | 6.70 | 5.98 | 7.98 | 9.02 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Alpa Laboratories Ltd | 14.20 | 1.57 | — |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare ALPA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ALPA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAlpa Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Vaswani Industries Ltd, FCS Software Solutions Ltd, Meera Industries Ltd and Zee Media Corporation Ltd are among the other gainers in the BSE's 'B' group today, 27 September 2024.Alpa Laboratories Ltd spiked 15.89% to Rs 128 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 78903 shares were traded on the counter so far as against the average daily volumes of 49367 shares in the past one month. Vaswani Industries Ltd soared 12.94% to Rs 58.91. The stock was the second biggest gainer in 'B' group. On the BSE, 1.2 lakh shares were traded on the counter so far as against the average daily volumes of 45791 shares in the past one month. FCS Software Solutions Ltd surged 12.39% to Rs 3.81. The stock was the third biggest gainer in 'B' group. On the BSE, 80.6 lakh shares were traded on the counter so far as against the average daily volumes of 13.1 lakh shares in the past one month. Meera Industries Ltd added 10.00% to Rs 108.24. The stock was the fourth biggest gainer in 'B' group. On the BSE, 41696 shares were traded on the counter so far as against the average daily volumes of 49229 shares in the past one month. Zee Media Corporation Ltd gained 9.99% to Rs 20.7. The stock was the fifth biggest gainer in 'B' group. On the BSE, 86.23 lakh shares were traded on the counter so far as against the average daily volumes of 13.89 lakh shares in the past one month. Powered by Capital Market - Live
Alpa Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Net profit of Alpa Laboratories rose 68.32% to Rs 5.10 crore in the quarter ended June 2024 as against Rs 3.03 crore during the previous quarter ended June 2023. Sales declined 15.69% to Rs 21.44 crore in the quarter ended June 2024 as against Rs 25.43 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales21.4425.43 -16 OPM %2.47-4.48 - PBDT5.643.28 72 PBT5.103.00 70 NP5.103.03 68 Powered by Capital Market - Live
Net profit of Alpa Laboratories rose 68.98% to Rs 5.12 crore in the quarter ended June 2024 as against Rs 3.03 crore during the previous quarter ended June 2023. Sales declined 15.69% to Rs 21.44 crore in the quarter ended June 2024 as against Rs 25.43 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales21.4425.43 -16 OPM %2.47-4.48 - PBDT5.643.28 72 PBT5.103.00 70 NP5.123.03 69 Powered by Capital Market - Live
Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Alpa Laboratories Ltd leads losers in ‘B’ group
Globalspace Technologies Ltd leads losers in ‘B’ group
Alpa Laboratories Ltd leads gainers in ‘B’ group
Kaya Ltd leads gainers in ‘B’ group
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 8.22%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.04% to 0.03%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 75.43%, vs industry avg of 15.28%